Company profileSME (from the award notice)
2care4 ApS
- Legal form
- A/S
- Seat
- Esbjerg V, Denmark
Also named in notices: 2care4 Aps
Based on the notices and sources Inteliwert covers; not a complete record. Last checked 1 December 2025.
Identifiers
Not found in the indexed notices.
Track record in public tenders
Awards in the covered notices over the last 36 months, per CPV division.
| CPV division | Awards | Award value (excl. VAT) | Buyers | Repeat buyers | First award | Last award |
|---|---|---|---|---|---|---|
| 33 Medical equipments, pharmaceuticals and personal care products | 3 | — | 1 | 1 | 1 October 2024 | 1 December 2025 |
Awards
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tocilizumab (ausschließlich Fertigspritze und Fertigpen), ATC L04AC07 für die Zeit 01.12.2025 - 30.11.2027Buyer: DAK-Gesundheit · Awarded: 1 December 2025 · CPV 33600000
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dapagliflozin, ATC A10BK01 für die Zeit 01.10.2024 - 30.09.2026Buyer: DAK-Gesundheit · Awarded: 1 October 2024 · CPV 33600000
- Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Faricimab, ATC S01LA09 für die Zeit 01.10.2024 - 30.09.2026Buyer: DAK-Gesundheit · Awarded: 1 October 2024 · CPV 33600000
Certifications and prequalification
No certification or prequalification found in the covered sources.
A certification missing here is unknown, not absent.
Website and LinkedIn
Not found in the indexed notices.
Open tenders that might fit
Possible match based on public information
Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.
-
OpenTenderSME (from the award notice)
1/DLII6/VM131 - RV div. Arzneimittel
Reasons
- Won a contract in CPV group 336 (2025-12-01) Evidence · checked 9 Nov 2026
- 3 awards in this field in 36 months, from 1 buyer Evidence · checked 9 Nov 2026
Last checked 4 Nov 2026, 16:10 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Dynamisches Beschaffungssystem Arzneimittel
Reasons
- Won a contract in CPV group 336 (2025-12-01) Evidence · checked 9 Nov 2026
- 3 awards in this field in 36 months, from 1 buyer Evidence · checked 9 Nov 2026
Last checked 9 Nov 2026, 03:31 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Open-House-Rabattverträge 2026-21 Lisdexamfetamin (90 St.)
Reasons
- Won a contract in CPV group 336 (2025-12-01) Evidence · checked 8 Nov 2026
- Seat outside the country of performance Evidence · checked 8 Nov 2026
- 3 awards in this field in 36 months, from 1 buyer Evidence · checked 8 Nov 2026
Last checked 4 Nov 2026, 13:10 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Testkits zum molekularbiologischen Nachweis des Virus der Afrikanischen Schweinepest, der Europäischen Schweinepest sowie der Blauzungenkrankheit mittels real-time PCR
Reasons
- Won a contract in CPV group 336 (2024-10-01) Evidence · checked 7 Nov 2026
- 2 awards in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 14:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
1/DLII6/VM154 - RV Arzneimittel, divers
Reasons
- Won a contract in CPV group 336 (2024-10-01) Evidence · checked 7 Nov 2026
- 2 awards in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 6 Nov 2026, 21:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Arzneimittelverträge mit Beitrittsoption
Reasons
- Won a contract in CPV group 336 (2024-10-01) Evidence · checked 7 Nov 2026
- 2 awards in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 13:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Open-House-Verträge 2026-3
Reasons
- Won a contract in CPV group 336 (2024-10-01) Evidence · checked 7 Nov 2026
- 2 awards in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 22:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Open-House-Verträge 2026 - Aflibercept (Kopie)
Reasons
- Won a contract in CPV group 336 (2024-10-01) Evidence · checked 7 Nov 2026
- 2 awards in this field in 36 months, from 1 buyer Evidence · checked 7 Nov 2026
Last checked 7 Nov 2026, 04:30 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Open House Originale Rabattverträge 2025-05 - Emtricitabin/Tenofovirdisoproxil/Rilpivirin (Wirkstoffkombination)
Reasons
- Won a contract in CPV group 336 (2025-12-01) Evidence · checked 9 Nov 2026
- Seat outside the country of performance Evidence · checked 9 Nov 2026
- 3 awards in this field in 36 months, from 1 buyer Evidence · checked 9 Nov 2026
Last checked 9 Nov 2026, 03:31 (UTC+01:00)Official notice -
OpenTenderSME (from the award notice)
Open house Arzneimittelrabattverträge zum Wirkstoff Dimethylfumarat, ATC L04AX07
Reasons
- Won a contract in CPV group 336 (2025-12-01) Evidence · checked 8 Nov 2026
- Seat outside the country of performance Evidence · checked 8 Nov 2026
- 3 awards in this field in 36 months, from 1 buyer Evidence · checked 8 Nov 2026
Last checked 8 Nov 2026, 08:30 (UTC+01:00)Official notice
Is this your company?
Send corrections, or ask us to remove the profile, to hello@inteliwert.com. You can also ask that the company never be tagged on LinkedIn.
About this profile
Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances.
Based on the notices and sources Inteliwert covers; not a complete record.
Last checked 1 December 2025.